Annexon (ANNX) Non-Current Deffered Revenue (2019 - 2021)
Annexon's (ANNX) quarterly Non-Current Deffered Revenue came in at $946000.0 in Q1 2021, down 9.56% quarter-over-quarter from $1.0 million in Q4 2020.
Annexon (ANNX) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Annexon's Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $946000.0 for Q1 2021.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $946000.0 in Q1 2021; TTM through Mar 2021 was $946000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $1.0 million, down 27.21% from the prior year.
- Non-Current Deffered Revenue fell to $946000.0 in Q1 2021 per ANNX's latest filing, from $1.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $1.4 million in Q4 2019 and bottomed at $946000.0 in Q1 2021.
- The 3-year median for Non-Current Deffered Revenue is $1.1 million (2020), against an average of $1.2 million.
- Biggest YoY gain for Non-Current Deffered Revenue was 27.21% in 2020; the steepest drop was 27.21% in 2020.
- Year by year, Non-Current Deffered Revenue stood at $1.4 million in 2019, then decreased by 27.21% to $1.0 million in 2020, then declined by 9.56% to $946000.0 in 2021.
- Per Business Quant, the three latest ANNX Non-Current Deffered Revenue figures stand at $946000.0 (Q1 2021), $1.0 million (Q4 2020), and $1.1 million (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 946,000.00 |
| Dec 31, 2020 | 1.05 Mn |
| Sep 30, 2020 | 1.15 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Dec 31, 2019 | 1.44 Mn |